NF2 and neoplasm: Prior work demonstrated increased vascular endothelial growth factor (VEGF) expression in NF2-associated vestibular schwannomas, and initial studies utilizing bevacizumab demonstrated both decreased tumor volume and hearing improvement in a subset of patients [117,119].